SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following its earnings, which revealed a significant strategic pivot from auto manufacturing, including the end of Model S/X production, towards a future centered on AI and robotics, sparking intense debate among investors about its ambitious new direction versus current financial metrics.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending after crushing Q4 earnings and issuing strong guidance, with its aggressive AI capital expenditure program sparking both enthusiastic analyst upgrades and debate among investors about the long-term return on investment.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending lower post-earnings despite beating expectations, as substantial AI capital expenditures and slightly decelerating Azure growth spark community debate over the immediate return on its AI and OpenAI investments, leading to divided sentiment between those seeing a buying opportunity and those cautious about the heavy spending.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending after a new Gotham City Research report alleged over a billion in overstated earnings and undisclosed related-party transactions with its CEO's father's company, fueling intense community debate about the legitimacy of its business model and drawing comparisons to past financial scandals.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is experiencing a significant sell-off despite reporting strong quarterly results, accelerated AI offerings, and announcing a substantial share buyback, as the market questions valuations and the impact of AI on the broader SaaS sector. The community is sharply divided, with some viewing this as a major disconnect and a buying opportunity, while others express concern over perceived market manipulation and the future of software stocks.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a "parabolic" rise to new highs, with the community buzzing about intensifying geopolitical tensions, persistent concerns over the US Dollar's stability, and significant central bank accumulation solidifying its status as a top-tier safe-haven asset.

Virtuix Holdings, Inc.is a technology and entertainment company. It focuses on developing virtual reality (VR) hardware and software. The company was founded by Jan Goetgeluk on December 20, 2013 and is headquartered in Austin, TX.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix (VTIX) is experiencing explosive volatility following its Nasdaq listing, driven by reported 138% year-over-year revenue growth. The community is actively speculating about a tight float and potential for a short squeeze, drawing comparisons to other high-flying direct listings.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

A Reuters report suggesting the administration is stepping back from critical mineral price guarantees sparked an MP Materials sell-off, but the community quickly rallied behind MP's strong rebuttal that its binding Department of Defense deal, including a price floor, remains fully intact, prompting aggressive dip-buying.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending following the completion of its Astria Therapeutics acquisition, which integrated new assets and issued shares to former Astria holders, coinciding with a reported 9% Orladeyo price increase and 2025 revenue beat. The community's conversation centers on potential selling pressure from the newly issued shares and persistent frustration over perceived undervaluation, high short interest, and conservative 2026 guidance.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is actively discussed amidst market volatility driven by President Trump's contrasting announcements regarding defense contractor profitability and a proposed massive increase to the military budget, while the company also secures a long-term missile production expansion and navigates ongoing geopolitical tailwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of "Moderate Buy" from Analysts

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the firm, MarketBeat Ratings reports. One analyst...

Short Interest in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Rises By 52.5%

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totaling 10,830,747 shares, a...

Lexeo Therapeutics (NASDAQ:LXEO) Shares Gap Down - Here's What Happened

Lexeo Therapeutics (NASDAQ:LXEO) Shares Gap Down - What's Next...

Lexeo Therapeutics (NASDAQ:LXEO) Trading Up 9% - Still a Buy?

Lexeo Therapeutics (NASDAQ:LXEO) Trading Up 9% - Here's Why...

Lexeo Therapeutics (NASDAQ:LXEO) Shares Down 5.5% - What's Next?

Lexeo Therapeutics (NASDAQ:LXEO) Trading Down 5.5% - Here's What Happened...

Lexeo Therapeutics (NASDAQ:LXEO) Shares Down 3.5% - Here's What Happened

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Down 3.5% - Time to Sell...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) has earned an average rating of "Moderate Buy" from the ten research firms that are currently covering the firm, MarketBeat Ratings reports...

Lexeo Therapeutics (NASDAQ:LXEO) Sets New 52-Week High - Time to Buy?

Lexeo Therapeutics (NASDAQ:LXEO) Sets New 52-Week High - Here's What Happened...

Lexeo Therapeutics (NASDAQ:LXEO) Upgraded by Raymond James Financial to Strong-Buy Rating

Raymond James Financial raised shares of Lexeo Therapeutics to a "strong-buy" rating in a research note on Wednesday...

Frazier Life Sciences Management L.P. Has $17.79 Million Position in Lexeo Therapeutics, Inc. $LXEO

Frazier Life Sciences Management L.P. lifted its holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) by 363.1% in the 2nd quarter, according to the company in its most recent disclosure...

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

LXEO
Lexeo Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LXEO News

LXEOLexeo Therapeutics Inc.